(Q36327065)

13 August 2017

1 reference

title

Towards an improved serogroup B Neisseria meningitidis vaccine (English)

1 reference

13 August 2017

Neisseria meningitidis

1 reference

2

Andrew J Pollard

1 reference

13 August 2017

Kirsten P Perrett

1

1 reference

PubMed ID

16318425

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Expert Opinion on Biological Therapy

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

12

1 reference

13 August 2017

1611-1625

1 reference

Vaccine prevention of meningococcal disease, coming soon?

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

21 January 2018

Meningococcal disease

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

The future of meningococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Update on meningococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Development of vaccines against meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Mechanisms of neisserial serum resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Molecular typing methods for Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Use of variable-number tandem repeats to examine genetic diversity of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Multi-locus sequence typing: a tool for global epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

21 January 2018

The meningococcus tamed?

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Neisseria meningitidis Infections in Northern Norway: An Epidemic in 1974-1975 Due Mainly to Group B Organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Serotypes and polyacrylamide gel electrophoresis types among disease-associated isolates of group B Neisseria meningitidis in Spain, 1976-1979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Immunologic response of man to group B meningococcal polysaccharide vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Molecular mimetics of Neisseria meningitidis serogroup B polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Meningococcal carriage among local inhabitants during the pilgrimage 2000-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Meningococcal surrogates of protection--serum bactericidal antibody activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Serologic correlates of protection for evaluating the response to meningococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Neisseria lactamica protects against experimental meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Meningococcal serogroup B infections: a search for a broadly protective vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Development of natural immunity to Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Peptide mimics elicit antibody responses against the outer-membrane lipooligosaccharide of group B neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Functional genomics of Neisseria meningitidis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Immunization of mice with Neisseria meningitidis serogroup B genomic expression libraries elicits functional antibodies and reduces the level of bacteremia in an infant rat infection model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Generation and characterization of a PhoP homologue mutant of Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.12.1611

10.1517/14712598.5.12.1611

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16318425